PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
-13.99%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(-8.8%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
5.87%
Top 10 Holdings %
Top 10 Hldgs %
59.55%
Holding
44
New
5
Increased
14
Reduced
14
Closed
10
Top Buys
| 1 |
United Therapeutics
UTHR
|
$9.92M |
| 2 |
uniQure
QURE
|
$8.23M |
| 3 |
MeiraGTx Holdings
MGTX
|
$5.39M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$3.65M |
| 5 |
AC Immune
ACIU
|
$3.39M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$5.35M |
| 2 |
Zimmer Biomet
ZBH
|
$5.03M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$5.01M |
| 4 |
Q32 Bio
QTTB
|
$3.91M |
| 5 |
Indaptus Therapeutics
INDP
|
$3.54M |
Sector Composition
| 1 | Healthcare | 97.96% |
| 2 | Industrials | 2.04% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zimmer Biomet
ZBH
$21B
| $17.6M | 9.75% | 128,000 -36,619 | -22% | -$5.03M |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $15.5M | 8.58% | 304,900 -105,590 | -26% | -$5.35M |
|
3
Kura Oncology
KURA
$686M
| $13.5M | 7.47% | 888,152 +20,342 | +2% | +$309K |
|
|
4
uniQure
QURE
$896M
| $12.9M | 7.18% | 328,978 +208,978 | +174% | +$8.23M |
|
|
5
United Therapeutics
UTHR
$13.8B
| $10.6M | 5.88% | 132,937 +124,337 | +1,446% | +$9.92M |
|
|
HNGR
6
DELISTED
Hanger Inc.
HNGR
| $8.05M | 4.47% | 395,000 -96,685 | -20% | -$1.97M |
|
7
UroGen Pharma
URGN
$900M
| $7.75M | 4.3% | 325,385 +64,457 | +25% | +$1.54M |
|
|
ARNA
8
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.47M | 4.14% | 163,133 -1,167 | -0.7% | -$53.4K |
|
9
Centene
CNC
$14.3B
| $7.14M | 3.96% | 165,000 +38,500 | +30% | +$1.67M |
|
10
Iovance Biotherapeutics
IOVA
$807M
| $6.3M | 3.49% | 346,149 -53,851 | -13% | -$980K |
|
|
11
AC Immune
ACIU
$205M
| $6.18M | 3.43% | 1,248,453 +684,553 | +121% | +$3.39M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.06M | 3.36% | 89,952 +38,752 | +76% | +$2.61M |
|
|
SBBP
13
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.01M | 3.33% | 2,515,072 -31,925 | -1% | -$76.3K |
|
|
14
MeiraGTx Holdings
MGTX
$587M
| $5.39M | 2.99% | +338,096 | New | +$5.39M |
|
|
ALBO
15
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $5.05M | 2.8% | 252,500 -827 | -0.3% | -$16.5K |
|
|
RETA
16
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.03M | 2.79% | 62,591 -62,374 | -50% | -$5.01M |
|
17
Aldeyra Therapeutics
ALDX
$351M
| $4.17M | 2.31% | 790,228 +92,307 | +13% | +$487K |
|
|
RCM
18
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.65M | 2.03% | +408,958 | New | +$3.65M |
|
19
Humana
HUM
$36.5B
| $3.07M | 1.7% | +12,000 | New | +$3.07M |
|
20
AbbVie
ABBV
$372B
| $2.95M | 1.64% | +39,000 | New | +$2.95M |
|
|
21
Q32 Bio
QTTB
$20.9M
| $2.78M | 1.54% | 153,303 -215,745 | -58% | -$3.91M |
|
22
Gyre Therapeutics
GYRE
$703M
| $2.74M | 1.52% | 558,159 +11,067 | +2% | +$54.3K |
|
23
Guardant Health
GH
$8.41B
| $2.66M | 1.48% | +41,700 | New | +$2.66M |
|
|
ARQL
24
DELISTED
Arqule Inc
ARQL
| $2.62M | 1.45% | 364,797 +281,122 | +336% | +$2.02M |
|
25
ADMA Biologics
ADMA
$4.12B
| $2.44M | 1.35% | 548,409 +362,688 | +195% | +$1.61M |
|